Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure

Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure

Item
http://www.wikidata.org/entity/Q34617168
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and womenBeneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism.New insights on the role of the endocannabinoid system in the regulation of energy balance.Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic AdmixtureCardiovascular biomarkers and sex: the case for women.Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian menCannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication.Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS.Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders.Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism.
P2860

Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure

Item
http://www.wikidata.org/entity/Q34617168
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Central and peripheral endocan ...... posity, and energy expenditure
@ast
Central and peripheral endocan ...... posity, and energy expenditure
@en
Central and peripheral endocan ...... posity, and energy expenditure
@nl
type
label
Central and peripheral endocan ...... posity, and energy expenditure
@ast
Central and peripheral endocan ...... posity, and energy expenditure
@en
Central and peripheral endocan ...... posity, and energy expenditure
@nl
prefLabel
Central and peripheral endocan ...... posity, and energy expenditure
@ast
Central and peripheral endocan ...... posity, and energy expenditure
@en
Central and peripheral endocan ...... posity, and energy expenditure
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Central and peripheral endocan ...... posity, and energy expenditure
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932